Compare D & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | D | IDXX |
|---|---|---|
| Founded | 1983 | 1983 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7B | 57.1B |
| IPO Year | N/A | N/A |
| Metric | D | IDXX |
|---|---|---|
| Price | $64.60 | $636.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $64.33 | ★ $715.00 |
| AVG Volume (30 Days) | ★ 5.4M | 546.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.79 | $10.81 |
| Revenue Next Year | $6.59 | $8.62 |
| P/E Ratio | ★ $21.27 | $47.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $48.07 | $356.14 |
| 52 Week High | $67.57 | $769.98 |
| Indicator | D | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 63.38 | 39.61 |
| Support Level | $61.62 | $606.04 |
| Resistance Level | $67.57 | $651.57 |
| Average True Range (ATR) | 1.41 | 18.78 |
| MACD | 0.36 | -1.74 |
| Stochastic Oscillator | 63.06 | 37.23 |
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.